Chris Callas is currently the Finance Director for Commercial Finance in Vaccines at Pfizer, having transitioned through roles including Finance Sr. Manager in Oncology and Finance Manager since 2021. Chris previously held various finance positions at Ortho Clinical Diagnostics and Cordis, where they excelled in responsibilities such as budget forecasting, financial analysis, and commercial finance management. Chris began their career as a Financial Analyst at Ortho Clinical Diagnostics and earned a Bachelor's degree in Finance from Rutgers University, graduating with a 3.85 GPA in 2009.
This person is not in the org chart
This person is not in any teams
This person is not in any offices